Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Clearwater Paper has successfully transitioned into a pure-play paperboard supplier by divesting its tissue business and acquiring the Augusta, Georgia facility. However, the company is currently navigating a cyclical low point characterized by soft Solid Bleached Sulfate (SBS) market pricing and high maintenance costs. While the balance sheet has been significantly de-leveraged, near-term profitability remains under pressure, making a recovery in industry utilization rates to 90% the primary catalyst for an earnings inflection in 2027.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets4 analysts · as of 18 Aug 2026
Low · most bearish analyst$17.00
Mean target$18.00
High · most bullish analyst$19.00
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$12.0020%

Industry utilization rates remain depressed below 85% due to persistent overcapacity or macroeconomic slowdown. Input cost inflation (energy, logistics, and fiber) outpaces productivity gains, and further weather or operational disruptions depress Adjusted EBITDA, forcing reliance on credit facilities.

Base CaseCentral scenario
$17.0050%

SBS market pricing remains soft through the remainder of 2026, offset by gradual productivity gains and cost-saving initiatives (such as the Cypress Bend restructuring). The company achieves its full-year revenue guidance of $1.4 billion to $1.5 billion, with free cash flow hovering near breakeven as it absorbs major maintenance outages.

Bull CaseUpside scenario
$23.0030%

A rapid recovery in domestic demand and lower imports drive industry utilization rates back above 90% by late 2026. This tightens the SBS market, allowing Clearwater Paper to reclaim pricing power and leverage its expanded capacity from the Augusta acquisition, leading to a sharp earnings inflection in 2027.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Pure-play paperboard focus following the strategic divestiture of the consumer tissue business.
  • Significantly de-leveraged balance sheet with net debt reduced by $199 million using tissue sale proceeds, achieving a net leverage ratio of 1.1x at year-end 2024.
  • Substantial capacity expansion (approx. 75% increase) via the Augusta, Georgia facility acquisition.
Sign in / Sign up to read more
Key Investment Risks
  • Cyclical downturn in the paperboard industry with SBS utilization rates in downcycle territory.
  • Near-term margin compression from lower market pricing and elevated maintenance outage costs.
  • Exposure to input cost inflation (energy, chemicals, and logistics) and severe weather events.
Sign in / Sign up to read more
Thesis Invalidation Triggers
  1. Failure to achieve projected annual cost savings of $8 million to $12 million from the Cypress Bend restructuring.
  2. A prolonged delay in industry utilization recovery past 2026, preventing a 2027 pricing rebound.
  3. Inability to recover remaining representation and warranty insurance claims under the $50 million policy limit.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.